Australia Plans Changes To GMP Fee Structure To Help Cover Costs
Executive Summary
Australia is planning changes to the way it charges pharmaceutical manufacturers for activities related to good manufacturing practice, such as inspections, because the current arrangements do not allow it to recover its costs.